LeMaitre Vascular (NSDQ:LMAT) said it plans to lay off about 10% of its workforce, or about 30 employees, even as it comes off of a record sales performance during the 4th quarter.
MassDevice Earnings Roundup
Listen to Volcano’s Q4 2013 earnings call
Volcano sinks on another missed quarter, bad news in Japan
Pessimistic Wright Medical wins FDA date for Augment
Wright Medical (NSDQ:WMGI) said it’s not optimistic about an FDA dispute resolution panel on its Augment biologic bone graft product, now slated for May, and would quickly move to cut costs at the BioMimetic Therapeutics subsidiary it bought back in 2012.
Listen to DexCom’s Q4 2013 earnings call
DexCom revenues soar in 2013 but charges sink the bottom line
California diabetes devices maker DexCom Inc. (NSDQ:DXCM) posted a major boost to its top line, posting a 62% increase in sales for its 4th quarter of 2013.
Write-downs inflate DJO’s Q4 losses
DJO Global’s public reporting subsidiary posted a major increase in losses for its 4th quarter, driven primarily by a $106.6 million goodwill write-down that nearly tripled the company’s red ink.
DJO posted a 180% increase in losses on an 8% increase on sales during the quarter, as well as a 71% increase in losses and a 4% increase in sales for fiscal 2013.
Syneron names new CEO, beats The Street and buys New Star Lasers
Israeli device maker Syneron Medical Ltd. (NSDQ:ELOS) made some major moves this month, announcing a new CEO alongside strong Q4 earnings and signing a deal to acquire New Lasers Inc.
Hansen Medical CEO Barclay is out after Q4 slip to red
Hansen Medical (NSDQ:HNSN) is looking for a new CEO to replace Bruce Barclay, who was let go after the robotic surgery company reported a slide to red ink for the 4th quarter.